1287 related articles for article (PubMed ID: 19785596)
1. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous lupus erythematosus: clinical and immunological study of 308 patients stratified by gender.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Clin Exp Dermatol; 2010 Oct; 35(7):729-35. PubMed ID: 20015282
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW; Sontheimer RD
Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous manifestations of systemic lupus erythematosus.
Yell JA; Mbuagbaw J; Burge SM
Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced lupus: an update on its dermatologic aspects.
Marzano AV; Vezzoli P; Crosti C
Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
[TBL] [Abstract][Full Text] [Related]
6. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus.
Schmitt V; Meuth AM; Amler S; Kuehn E; Haust M; Messer G; Bekou V; Sauerland C; Metze D; Köpcke W; Bonsmann G; Kuhn A
Br J Dermatol; 2010 Jan; 162(1):64-73. PubMed ID: 19712116
[TBL] [Abstract][Full Text] [Related]
7. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus.
Cohen MR; Crosby D
J Rheumatol; 1994 Sep; 21(9):1665-9. PubMed ID: 7799346
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI.
Bein D; Kuehn E; Meuth AM; Amler S; Haust M; Nyberg F; Sauerland C; Luger TA; Bonsmann G; Kuhn A
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):652-9. PubMed ID: 20849444
[TBL] [Abstract][Full Text] [Related]
9. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
10. Classification of lupus erythematosus based upon Japanese patients.
Tsuchida T
Autoimmun Rev; 2009 May; 8(6):453-5. PubMed ID: 19162249
[TBL] [Abstract][Full Text] [Related]
11. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings.
Hasan T; Nyberg F; Stephansson E; Puska P; Häkkinen M; Sarna S; Ros AM; Ranki A
Br J Dermatol; 1997 May; 136(5):699-705. PubMed ID: 9205502
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.
Järvinen TM; Hellquist A; Koskenmies S; Einarsdottir E; Koskinen LL; Jeskanen L; Berglind L; Panelius J; Hasan T; Ranki A; Kere J; Saarialho-Kere U
Exp Dermatol; 2010 Feb; 19(2):123-31. PubMed ID: 19758313
[TBL] [Abstract][Full Text] [Related]
13. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings.
Bangert JL; Freeman RG; Sontheimer RD; Gilliam JN
Arch Dermatol; 1984 Mar; 120(3):332-7. PubMed ID: 6703733
[TBL] [Abstract][Full Text] [Related]
14. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
Popovic K; Nyberg F; Wahren-Herlenius M; Nyberg F
Arthritis Rheum; 2007 Jan; 56(1):255-64. PubMed ID: 17195229
[TBL] [Abstract][Full Text] [Related]
15. [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy].
Ruzicka T; Bieber T; Meurer M
Wien Klin Wochenschr; 1987 Dec; 99(23):802-7. PubMed ID: 3324494
[TBL] [Abstract][Full Text] [Related]
16. [Lupus erythematosus].
Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
[TBL] [Abstract][Full Text] [Related]
17. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
Tebbe B; Orfanos CE
Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
[TBL] [Abstract][Full Text] [Related]
18. Subacute cutaneous lupus erythematosus in Greece. A clinical, serological and genetic study.
Drosos AA; Dimou GS; Siamopoulou-Mavridou A; Hatzis J; Moutsopoulos HM
Ann Med Interne (Paris); 1990; 141(5):421-4. PubMed ID: 2256585
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced lupus erythematosus.
Marzano AV; Tavecchio S; Menicanti C; Crosti C
G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
[TBL] [Abstract][Full Text] [Related]
20. Ten-year retrospective clinicohistological study of cutaneous lupus erythematosus in Korea.
Oh EH; Kim EJ; Ro YS; Ko JY
J Dermatol; 2018 Apr; 45(4):436-443. PubMed ID: 29423919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
